Literature DB >> 19671462

Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H.

Marian L Logrip1, Patricia H Janak, Dorit Ron.   

Abstract

Alcoholism is a pervasive social problem, and thus understanding factors that regulate alcohol (ethanol) reward is important for designing effective therapies. One putative regulatory system includes the kappa opioid receptor (KOR) and its endogenous ligand, dynorphin. Previously, we demonstrated that acute ethanol increased preprodynorphin expression via brain-derived neurotrophic factor (BDNF) in striatal neurons, and that blockade of the KOR attenuated decreases in ethanol intake observed following increased expression of BDNF. As high doses of KOR agonists can generate an aversive state, we hypothesized that endogenous dynorphin may regulate ethanol intake by interfering with the rewarding properties of ethanol. We found that low, nonaversive doses of the KOR agonist U50,488H blocked the rewarding properties of ethanol during conditioning, thus impairing the acquisition of conditioned place preference. Importantly, we demonstrate that U50,488H also inhibited the conditioned increase in locomotor activation normally observed in the ethanol-paired chamber on test day. Taken together, these data indicate that the KOR/dynorphin system may acutely regulate ethanol intake via inhibition of the rewarding properties of ethanol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671462      PMCID: PMC3784271          DOI: 10.1016/j.alcohol.2009.05.001

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  34 in total

1.  Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats.

Authors:  P W Marinelli; K Kiianmaa; C Gianoulakis
Journal:  Life Sci       Date:  2000-04-07       Impact factor: 5.037

2.  Association of the kappa-opioid system with alcohol dependence.

Authors:  X Xuei; D Dick; L Flury-Wetherill; H-J Tian; A Agrawal; L Bierut; A Goate; K Bucholz; M Schuckit; J Nurnberger; J Tischfield; S Kuperman; B Porjesz; H Begleiter; T Foroud; H J Edenberg
Journal:  Mol Psychiatry       Date:  2006-08-22       Impact factor: 15.992

3.  Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens.

Authors:  A M Pliakas; R R Carlson; R L Neve; C Konradi; E J Nestler; W A Carlezon
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

4.  The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.

Authors:  S Lindholm; M Werme; S Brené; J Franck
Journal:  Behav Brain Res       Date:  2001-05       Impact factor: 3.332

5.  Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system.

Authors:  Jay P McLaughlin; Shuang Li; Joseph Valdez; Theodore A Chavkin; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

Review 6.  Behavioral neurobiology of alcohol addiction: recent advances and challenges.

Authors:  Friedbert Weiss; Linda J Porrino
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 7.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

8.  Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.

Authors:  Brendan M Walker; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-05-02       Impact factor: 7.853

9.  Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake.

Authors:  Marian L Logrip; Patricia H Janak; Dorit Ron
Journal:  FASEB J       Date:  2008-02-29       Impact factor: 5.191

10.  The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.

Authors:  Benjamin B Land; Michael R Bruchas; Julia C Lemos; Mei Xu; Erica J Melief; Charles Chavkin
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

View more
  35 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

2.  Early role of the κ opioid receptor in ethanol-induced reinforcement.

Authors:  Ricardo Marcos Pautassi; Michael E Nizhnikov; Ma Belén Acevedo; Norman E Spear
Journal:  Physiol Behav       Date:  2012-01-11

3.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2013-09-08       Impact factor: 3.046

Review 4.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

5.  The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.

Authors:  Xin Liu; Pi-Da Hao; Ming-Feng Yang; Jing-Yi Sun; Lei-Lei Mao; Cun-Dong Fan; Zong-Yong Zhang; Da-Wei Li; Xiao-Yi Yang; Bao-Liang Sun; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2017-05-06       Impact factor: 4.530

Review 6.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 7.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

8.  Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2019-08-27       Impact factor: 3.252

9.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

10.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.